Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV — Stella

View on ClinicalTrials.gov

Recruiting

Back to HIV trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Icahn School of Medicine at Mount Sinai, New York, New York

Key details

Phase

Early testing / Safety & dosing

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~207 participants

Started

August 2020

Primary completion

September 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.